LSB
LakeShore Biopharma
LSB
LSB
Delisted
LSB was delisted on the 19th of September, 2025.
7 hedge funds and large institutions have $330K invested in LakeShore Biopharma in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
7
Holding in Top 10
–
Calls
–
Puts
–
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $119K |
|
|||
|
HA
2
HHLR Advisors
Grand Cayman,
Cayman Islands
| $76.7K |
|
|||
|
O
3
OrbiMed
New York
| $55.9K |
|
|||
|
SCM
4
Superstring Capital Management
New York
| $31.4K |
|
|||
5
Barclays
London,
United Kingdom
| $25K |
|
|||
6
Citadel Advisors
Miami,
Florida
| $15.3K |
|
|||
7
UBS Group
Zurich,
Switzerland
| $6.6K |
|
|||
8
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – |
|
|||
|
TRCT
9
Tower Research Capital (TRC)
New York
| – |
|